SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech insider buys
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who started this subject12/26/2002 1:57:21 PM
From: tuck   of 213
 
Stefaan,

Just a heads up, as neither of these can be considered significant, but . . .

Insiders have been buying a little GNBT -- Generex -- which might be interesting because it focuses on buccal delivery of large molecules, notably insulin (with Lilly). It would presumably avoid the adverse affects seen by pulmonary delivery methods. Haven't even sneezed at it for a long time.

Also, the first ever buy in trickle company HBIO (after a long year of VC bailing), which seems like a value play now unless estimates are too optimistic.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News